R. Redmond-Misner

Are population‐based patient‐reported outcomes associated with overall survival in patients with advanced pancreatic cancer?

Kelvin K. W. Chan, L. Barbera, Helen Guo, 2019, Cancer medicine.

Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis

Kelvin K. W. Chan, C. Earle, R. McLeod, 2019, Cancer medicine.

Estimating the costs of intensity-modulated and 3-dimensional conformal radiotherapy in Ontario.

P. Warde, J. Hoch, E. Gutierrez, 2016, Current oncology.